Cargando…

Pulmonary Hypertension in Interstitial Lung Disease: Management Options to Move Beyond Supportive Care

PURPOSE OF REVIEW: This review delineates current diagnostic and management strategies for pulmonary hypertension due to interstitial lung disease (PH-ILD). RECENT FINDINGS: The INCREASE trial, a phase III multicenter, randomized, placebo-controlled trial demonstrated both improved 6-min walk distan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fabyan, Kimberly D., Chandel, Abhimanyu, King, Christopher S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200699/ https://www.ncbi.nlm.nih.gov/pubmed/37362782 http://dx.doi.org/10.1007/s13665-023-00311-2

Ejemplares similares

Pulmonary Hypertension in Interstitial Lung Disease: Updates in Disease, Diagnosis, and Therapeutics
por: Haynes, Zachary A., et al.
Publicado: (2023)

Antifibrotic Therapies and Progressive Fibrosing Interstitial Lung Disease (PF-ILD): Building on INBUILD
por: Shumar, John N., et al.
Publicado: (2021)

Prevalence of pulmonary hypertension in patients with COVID‐19 related lung disease listed for lung transplantation: A UNOS registry analysis
por: Thomas, Christopher, et al.
Publicado: (2023)

Recent advances in the management of pulmonary hypertension with interstitial lung disease
por: Waxman, Aaron B., et al.
Publicado: (2022)

Moving beyond first-line treatment options for OCD
por: Paxos, Chris
Publicado: (2022)

Pulmonary Artery Size in Interstitial Lung Disease and Pulmonary Hypertension: Association with Interstitial Lung Disease Severity and Diagnostic Utility
por: Chin, Matthew, et al.
Publicado: (2018)

Depression in Pulmonary Arterial Hypertension and Interstitial Lung Diseases
por: Verma, Sameer, et al.
Publicado: (2014)

Noninvasive determinants of pulmonary hypertension in interstitial lung disease
por: Joseph, Phillip, et al.
Publicado: (2023)

Incidence and prognostic significance of pleural effusions in pulmonary arterial hypertension
por: Chandel, Abhimanyu, et al.
Publicado: (2021)

The Challenge of Diagnosing and Managing Pulmonary Arterial Hypertension in Systemic Sclerosis with Interstitial Lung Disease
por: Zanatta, Elisabetta, et al.
Publicado: (2022)

Derivation and validation of a simple multidimensional index incorporating exercise capacity parameters for survival prediction in idiopathic pulmonary fibrosis
por: Chandel, Abhimanyu, et al.
Publicado: (2023)

Advanced interstitial lung fibrosis with emphysema and pulmonary hypertension with no evidence for interstitial lung disease on high resolution CT
por: Foris, Vasile, et al.
Publicado: (2019)

Beyond idiopathic pulmonary fibrosis: the world of progressive-fibrosing interstitial lung disease
por: Harari, Sergio
Publicado: (2018)

Moving beyond MARCO
por: Rosa, Nicholas, et al.
Publicado: (2023)

Predictors of mortality in interstitial lung disease patients without pulmonary hypertension
por: Alhamad, Esam H., et al.
Publicado: (2020)

Predictors of Mortality in Patients with Interstitial Lung Disease-Associated Pulmonary Hypertension
por: Alhamad, Esam H., et al.
Publicado: (2020)

Pulmonary hypertension in interstitial lung disease: an area of unmet clinical need
por: Dhont, Sebastiaan, et al.
Publicado: (2022)

Management and support of patients with fibrosing interstitial lung diseases
por: Barbera, Tyonn, et al.
Publicado: (2021)

Interstitial lung disease and pre-capillary pulmonary hypertension in neurofibromatosis type 1
por: Rodrigues, Daniela, et al.
Publicado: (2018)

Clinical Retrospective Analysis of Interstitial Lung Disease Patients Associated with Pulmonary Hypertension
por: Lv, Hongxia, et al.
Publicado: (2019)

Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
por: Guillén-Del-Castillo, Alfredo, et al.
Publicado: (2022)

Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection
por: Parikh, Raj, et al.
Publicado: (2022)

Response to letter to the editor “noninvasive determinants of pulmonary hypertension in interstitial lung disease”
por: Joseph, Phillip, et al.
Publicado: (2023)

Beyond the World Symposium on Pulmonary Hypertension: practical management of pulmonary arterial hypertension and evolving concepts
por: Vachiéry, Jean-Luc, et al.
Publicado: (2019)

Single Lung Transplant for Secondary Pulmonary Hypertension: The Right Option for the Right Patient
por: Housman, Brian, et al.
Publicado: (2023)

Moving Beyond the Endothelium is Still Challenging-Complex Interplay between Endothelin and Reactive Oxygen Species in Pulmonary Arterial Hypertension
por: Chung, Hyemoon, et al.
Publicado: (2019)

Managing tensions in assessment: moving beyond either–or thinking
por: Govaerts, Marjan J B, et al.
Publicado: (2018)

Management options for interstitial ectopic pregnancies: A case series
por: Kahramanoglu, Ilker, et al.
Publicado: (2017)

Moving beyond MTBE.
por: Tenenbaum, D J
Publicado: (2000)

Moving beyond COVID
por: Tandon, Rajiv
Publicado: (2022)

Moving beyond Titers
por: Brooks, Benjamin D., et al.
Publicado: (2022)

Pulmonary hypertension due to unclassified interstitial lung disease in a Pembroke Welsh corgi
por: MORITA, Tomoya, et al.
Publicado: (2018)

Inhaled Treprostinil in Pulmonary Hypertension in the Context of Interstitial Lung Disease: A Success, Finally
por: Behr, Jürgen
Publicado: (2021)

Beyond the Diagnosis of Group IV Pulmonary Hypertension: Chronic Thromboembolic Pulmonary Hypertension Mimickers
por: Chima, Noor Rehman, et al.
Publicado: (2020)

The Evolving Management and Treatment Options for Patients with Pulmonary Hypertension: Current Evidence and Challenges
por: Swisher, John W, et al.
Publicado: (2023)

Contemporary Biomarkers in Pulmonary Embolism Diagnosis: Moving beyond D-Dimers
por: Gkana, Androniki, et al.
Publicado: (2022)

Lung Ultrasound B-Lines in Interstitial Lung Disease: Moving From Diagnosis to Prognostic Stratification
por: Volpicelli, Giovanni
Publicado: (2020)

Lung transplantation outcome in adult surfactant-related interstitial lung disease: first evidence to move on
por: Manali, Effrosyni D., et al.
Publicado: (2023)

Severe pulmonary hypertension in idiopathic nonspecific interstitial pneumonia
por: Hallowell, Robert W., et al.
Publicado: (2012)

ABCA3-related interstitial lung disease beyond infancy
por: Li, Yang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_41slm3554j45gk6sj07ag8mcsd